10X Genomics Inc (TXG)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
11,167,256,000
EV to revenue ratio (TTM)
15.2
EV to ebitda
148.5
Financial Performance
Revenue (TTM)
616,911,000
Gross profit (TTM)
432,527,000
EBITDA
-41,201,000
Profitability
Operating margin (TTM)
-15.20%
Profit margin
-12.20%
Return on assets (TTM)
-5.05%
Return on equity (TTM)
-9.40%
Per Share Metrics
Revenue per share (TTM)
4.83
EPS
-0.6
Diluted EPS (TTM)
-0.6
Book value
6.34
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
1,250
PEG ratio
Price to sales ratio (TTM)
18.1
Price to book ratio (TTM)
11.93
Growth
Quarterly earnings growth (YoY)
-12.70%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
5
Hold
10
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.077